Explore › Intervention › HIV screening
Intervention

HIV screening

Also known as: AIDS (HTLV-III) screening AIDS Testing HIV AIDS Testing HIV screening HIV screening (procedure) HIV screening and ART eligibility assessment during pregnancy (CD4 count + WHO staging) HIV screening test HIV screening test (procedure) HIV-AIDS Testing Human immunodeficiency virus (HIV) screening Human immunodeficiency virus (HIV) screening (procedure) Human immunodeficiency virus screening +4 more
3 findings 1 paper 4 related entities View in graph →

Related entities

conditions
HIV infection1
outcomes
Proportion of uterus1
populations
Pregnant Women1
studys
PMC27824811

Findings (27)

None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Among 1,378 HIV-infected women enrolled during pregnancy, 38.3% met ART eligibility criteria (CD4 <200 or <350 with WHO stage III) during pregnancy, and this group had 23.7% mortality by 24 months in

Effect: improvement; 38.3%

Size: 38.3%
PMC2782481
Finding details → · Paper → · Graph →

Papers (1)